GENE ONLINE|News &
Opinion
Blog

2022-04-13| Special

Single Cell Sequencing Uncovers How Early Embryonic Cells Differentiate

by GeneOnline
Share To
The research team has proposed a single-cell sequencing technology known as EpiDamID, which is based on DamID (DNA adenine methyltransferase identification), a set of tools for identifying adenine sites on DNA, a molecular marker prone to methylation modifications. To further identify post-transcriptional modification sites in individual cells, they have extended the existing DamID functions, improving it to become EpiDamID, a sequencing tool that identifies histones performing post-transcriptional modifications.

It's free! Log in now to read

LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
EVENT
Scroll to Top